Alnylam Pharmaceuticals
ALNY
#553
Rank
$37.46 B
Marketcap
$289.40
Share price
-0.45%
Change (1 day)
90.31%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company